denali therapeutics stock forecast
According to our research DNLI stock is a bad long-term investment. The average price target is.
What Is The Current Price Target And Forecast For Denali Therapeutics Dnli
What are analysts forecasts for Denali Therapeutics stock.
. During the last trading day the stock fluctuated 487. DNLI delivered earnings and revenue surprises of 769 and 1573 respectively for the quarter ended June 2022. Denali Therapeutics Stock Performance NASDAQ DNLI opened at 2832 on Monday.
The company has a market capitalization of 349 billion a. DNLI IEX Real-Time Price USD 2832 047 169 At. US084 loss per share further deteriorated from US069 loss in 3Q 2021.
Denali Therapeutics Inc. The 12 analysts offering price forecasts for Denali Therapeutics have a median target of 8217 with a high estimate of. About the Denali Therapeutics Inc.
The best long-term short-term Denali Therapeutics share price. Denali Therapeutics Inc. The stocks fifty day moving average is 2964 and its two-hundred day moving.
As of 2022 October 27 Thursday current price of DNLI stock is 27950 and our data indicates that the asset price has. NASDAQDNLIs beta value is holding at 145 while the average true range ATR indicator is currently reading 233. 24 2022 when the stock price was at 3101.
Denali Therapeutics Price Performance. Denali Therapeutics Stock Forecast Over the next 52 weeks Denali Therapeutics has on average historically risen by 327 based on the past 4 years of stock performance. US356m down 33 from 3Q.
Denali Therapeutics Stock Forecast 4DN stock price prediction. Price target in 14 days. In the short term.
All figures shown in the chart above are for the trailing 12 month TTM period. There are some variant perceptions on Denali Therapeutics with the most bullish analyst valuing it at US105 and the most bearish at US3800 per share. The Wall Street analyst predicted that Denali Therapeutics s share price could reach 3900 by Jun 23 2023.
According to 21 stock analysts the average 12. DENALI THERAPEUTICS INC stock forecast by Wall Street Analysts. Do the numbers hold clues to what.
The average Denali Therapeutics stock price prediction forecasts a potential. The revenue forecast for this year has experienced a facelift with analysts now much more optimistic on its sales pipeline. The Denali Therapeutics Inc.
The average DENALI THERAPEUTICS INC stock forecast from last 6 month is 605 and this show a -1717. DNLI stock forecast Our latest prediction for Denali Therapeutics Incs stock price was made on the Aug. Find real-time DNLI - Denali Therapeutics Inc stock quotes company profile news and forecasts from CNN Business.
DNLI Stock Price Prediction 6467 12331 Upside Based on 3 Wall Street analysts offering 12 month price targets for Denali Therapeutics in the last 3 months. Shares of Denali Therapeutics stock opened at 2832 on Wednesday. November 9 2022 232 AM 1 min read Denali Therapeutics NASDAQDNLI Third Quarter 2022 Results Key Financial Results Revenue.
Stock price fell by -0325 on the last day Thursday 3rd Nov 2022 from 3073 to 3063. Denali Therapeutics Inc. DNLI share price has been in a bear cycle for the past year.
Investors have been pretty optimistic on Denali.
Sec Filing Denali Therapeutics
Articles With Denali Therapeutics Inc
Price Forecasting Models For Denali Therapeutics Inc Dnli Stock Ta Ton Viet 9798737153816 Amazon Com Books
Denali Therapeutics Inc 2019 Annual Report 10 K
Dnli Stock Price And Chart Nasdaq Dnli Tradingview
Denali Therapeutics Inc Stock Quote Stock Price For Dnli Prn Financialwrapper
Dnli Stock Forecast Price Targets And Analysts Predictions Tipranks
Will Denali Therapeutics Inc Dnli Report Negative Q2 Earnings What You Should Know
Russell Investments Group Ltd Acquires 36 710 Shares Of Denali Therapeutics Inc Nasdaq Dnli Etf Daily News
5 Things To Know About Biotech Denali Therapeutics And Its 250 Million Ipo Marketwatch
Dnli Stock Price And Chart Nasdaq Dnli Tradingview
Denali Therapeutics Inc Dnli Stock Price News Info The Motley Fool
Denali Therapeutics Stock Quote Dnli Stock Price News Charts Message Board Trades
Fda Fingers Tox Assessment As Cause Of Denali Clinical Hold Leaving Biotech With A To Do List To Regain Momentum Fierce Biotech
Denali Therapeutics Inc Dnli Stock Price Quote News Stock Analysis
Industry Analysts Just Made A Massive Upgrade To Their Denali Therapeutics Inc Nasdaq Dnli Revenue Forecasts
3q20 Good Times Roll On Nature Biotechnology
Denali Therapeutics Dnli 52 Week High At 55 02 Low At 20 88
Oppenheimer Says There S Room For Over 50 Gains In These 3 Stocks Nasdaq